Evidence map›Paper›PMID 42781636›Full record

ArticleCureus2026

Recurrent Hypokalemic Paralysis as the Initial Presentation of Primary Sjögren's Syndrome.

Noor Ehsan, Shahbaz Mahmood, Usman Amjad, Ali Abbas Zahid, Muhammad Hassan Nawaz

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Noor EhsanInternal Medicine, Gulab Devi Teaching Hospital, Lahore, PAK.
Shahbaz MahmoodInternal Medicine, Gulab Devi Teaching Hospital, Lahore, PAK.
Usman AmjadFamily Medicine, Gulab Devi Teaching Hospital, Lahore, PAK.
Ali Abbas ZahidInternal Medicine, Gulab Devi Teaching Hospital, Lahore, PAK.
Muhammad Hassan NawazInternal Medicine, Jinnah Hospital, Allama Iqbal Medical College, Lahore, PAK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Distal renal tubular acidosis (dRTA) is associated with autoimmune disorders, particularly Sjögren's syndrome. Hypokalemic muscle weakness due to dRTA is an uncommon presentation of Sjögren's syndrome and may mimic primary hypokalemic periodic paralysis, resulting in a diagnostic delay. We present the case of a 35-year-old woman who reported recurrent limb weakness in the presence of hypokalemia (serum potassium: 2.7 mmol/L). She had previously been diagnosed with primary hypokalemic periodic paralysis, but this diagnosis was challenged as she was found to have normal anion gap metabolic acidosis and an alkaline urine pH with significant potassium wasting. The patient reported the presence of subtle sicca symptoms only on direct questioning. Further workup revealed positive serology for Sjögren's syndrome. She was managed with potassium and sodium bicarbonate replacement and given oral steroids and azathioprine for long-term management. Following correction of electrolyte abnormalities, the patient's muscle strength improved significantly, and she regained functional mobility. Her metabolic acidosis also resolved, and she experienced no further episodes of weakness or electrolyte imbalance during 12 months of follow-up. Primary Sjögren's syndrome-associated distal RTA should be considered in patients presenting with recurrent hypokalemic paralysis, particularly in the presence of normal anion gap metabolic acidosis and alkaline urine pH. Early treatment prevents recurrent paralysis and long-term renal complications.

Indexed as

distal renal tubular acidosishypokalemiahypokalemic periodic paralysisnormal anion gap metabolic acidosisprimary sjögren's syndrome

Identifiers

PMID42781636
PMCPMC13600474

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.